Genetron Holdings Limited
GTH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 22.3% | 25.3% | 31.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 43.2% | 63.5% | 61.3% | 44.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -97.1% | -90.4% | -59.7% | -94.8% |
| Other Income/Exp. Net | -$0 | $0 | -$3 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$3 | -$1 |
| Tax Expense | $0 | -$0 | -$3 | -$0 |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -135.8% | -82.4% | -46.7% | -99.4% |
| EPS | -28.53 | -4.76 | -3.29 | -4.65 |
| % Growth | -499.4% | -44.7% | 29.2% | – |
| EPS Diluted | -28.53 | -4.76 | -3.29 | -4.65 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | -$3 | -$0 |
| EBITDA | -$1 | -$0 | -$0 | -$1 |
| % Margin | -100.1% | -86.5% | -47.5% | -193.5% |